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Comparison of the Diagnostic Value of the Standard
Tube Agglutination Test and the ELISA IgG and IgM in
Patients with Brucellosis
Background and Aims: Brucellosis is endemic in Turkey. Since it affects many organs and the symptoms are
non-specific, the diagnosis by clinical findings is difficult and may be easily missed. Many serological tests have
been used for the diagnosis of human brucellosis. This study compared the diagnostic value of the Brucella
standard tube agglutination test (SAT) with that of ELISA (Brucella specific IgG and IgM) tests in patients with
Brucella bacteremia.
Patients and Methods: Thirty-two patients with brucellosis who had positive blood and/or bone-marrow
cultures for Brucella species, and 20 healthy individuals as controls were included in the study.
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Results: At the end of the study SAT was positive in 30 of the 32 patients, ELISA IgG was positive in 26 and
ELISA IgM was positive in 32. Of the 20 control sera, all were negative in SAT, 1 was positive in ELISA IgG,
and 3 were positive in ELISA IgM. The positive predictive value of SAT was 100.0% and the negative value
was 90.9%. The positive and negative predictive values for ELISA IgG were 96.3% and 76.0%, and for ELISA
IgM were 90.9% and 89.5%, respectively.
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Conclusions: SAT may be preferred to ELISA in acute brucellosis because it is cheap and easily applicable.
Key Words: Brucellosis, ELISA, Standard tube agglutination test

Brusellozis Hastalarda ELISA IgG-IgM ve Standart Tüp Agglütinasyon
Testlerinin Tan›sal De¤erlerinin Karﬂ›laﬂt›r›lmas›
Giriﬂ ve Amaç: Brusellozis Türkiye’de endemik bir hastal›kt›r. Birçok organ› etkiledi¤i için semptomlar
nonspesifiktir. Klinik bulgulara göre tan› koymak oldukça zordur ve teﬂhis kolayca atlanabilir. ‹nsan brusellozis
olgular›n›n teﬂhisinde birçok serolojik test kullan›lmaktad›r. Brucella bakteriyemisi saptanan hastalarda
Brucella standart tüp aglütinasyon testi (SAT) ile ELISA’n›n (Brucella IgG ve IgM) tan› de¤erini karﬂ›laﬂt›rmay›
amaçlad›k.
Hastalar ve Yöntem: Kemik ili¤i ve/veya kan kültüründe Brucella spp üremesi olan 32 hasta ve kontrol grubu
olarak 20 sa¤l›kl› gönüllü çal›ﬂma kapsam›na al›nd›.
Bulgular: Çal›ﬂma sonunda 32 hastan›n 30’unda SAT, 26’s›nda ELISA IgG ve 32’sinde IgM pozitif bulundu.
SAT için pozitif prediktif de¤er %100, negatif prediktif de¤er %90.9 olarak saptand›. ELISA IgG ve IgM için
pozitif ve negatif prediktif de¤erler s›ras›yla %96.3 ve %76; %90.9 ve %86.5 olarak saptand›.
Sonuç: Daha ucuz ve kolay uygulanabilir olmas› nedeniyle akut brusellozis de “SAT” ELISA’ya tercih edilebilir.
Anahtar Sözcükler: Brusellozis, ELISA, Stadard Tüp Aglütinasyon Testi
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Introduction
Brucellosis is a zoonosis caused by bacteria of the genus Brucella, which affect both
humans and animals such as the cow, sheep, goat, camel and pig. Bacteria enter hosts
through the digestive tract via contaminated dairy products and animal feed, the
respiratory tract via aerosols, or the skin via contact with infected animals on farms or
in slaughterhouses. Since the symptoms of brucellosis are non-specific, the clinical
diagnosis of the disease is difficult. Therefore, the diagnosis must be supported and
confirmed by the isolation of the agent, mostly from blood culture or by the detection
of antibodies against bacterial antigens (1,2).
The gold standard in the diagnosis of brucellosis is the isolation of Brucella bacteria.
The isolation rate of the bacteria from blood cultures ranges from 47.1% to 94.1%,
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depending on the methods used and the period of
incubation (3,4). In the absence of bacteriologic
confirmation, a presumptive diagnosis can be made on
the basis of high or rising titers of specific antibodies. A
variety of serologic tests have been applied to brucellosis,
of which the standard agglutination test (SAT) is the most
widely used. More recently, the Brucella enzyme-linked
immunosorbent assay (ELISA) test was introduced into
clinical laboratories. The purpose of this study was to
compare the diagnostic value of SAT with that of Brucella
ELISA tests in patients with Brucella bacteremia.

Materials and Methods
The subjects of this study were 32 patients with
brucellosis who had positive blood and/or bone-marrow
cultures for Brucella species, and 20 healthy individuals as
controls. Both patients and controls were from the same
epidemiological area.
Patients were selected according to their clinical
symptoms and laboratory findings. Two blood samples
(10 ml each) and one bone marrow sample (sternal
aspirate, 1 ml) from patients were obtained aseptically
for culture. They were inoculated into BACTEC bottles
separately and incubated in the BACTEC 9240 system
(Becton-Dickinson, Maryland, USA) for 21 days. Bottles
giving a positive growth index during the incubation
period were Gram stained and then subcultured to both
chocolate agar and blood agar plates and incubated at 37
°C in a 5%-10% CO2 atmosphere. When this was not the
case, Gram staining and a blind subculture were
performed after 21 days. The isolates of Gram-negative
cocco-bacilli were identified by conventional methods
(e.g., motility; oxidase, catalase and urease activity;
glucose fermentation; and production of H2S). Brucella
spp. suspected isolates were confirmed by slide
agglutination using type-specific antisera (Murex
Diagnostics Dartford, United Kingdom).
Fifty-two sera samples from both groups were tested
for Brucella specific IgG and IgM antibodies by ELISA
using a commercial kit (Novum, Germany). The test was
performed and evaluated according to the kit procedure.
The same samples were also tested by SAT using B.
abortus antigen (Pendik Veterinary Institute, ‹stanbul,
Turkey). Sample dilutions started from 1:20 for SAT.
Samples with an antibody titer of 1:160 or greater were
considered positive.
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Results
In the patients, 30 of 32 samples gave positive results
with SAT (titer >1:160). In the same group, Brucella IgG
and IgM antibodies with ELISA were positive in 26 and 32
patients, respectively. In 24 of the patients both IgG and
IgM antibodies were detected. From 20 control sera, all
were negative (titer<1/80) in SAT, 1 was positive in
ELISA IgG and 3 were positive in ELISA IgM. The positive
predictive value of SAT was 100.0% and the negative
value was 90.9%. The positive and negative predictive
values for ELISA IgG were 96.3% and 76.0%, and for
ELISA IgM were 90.9% and 89.5%, respectively. The
sensitivity and specificity rates of SAT, ELISA IgG and
ELISA IgM tests were 93.7% and 100.0%, 81.3% and
95.0%, and 93.8% and 85.0%, respectively (Table).

Discussion
In the absence of a positive culture, the diagnosis of
brucellosis rests on the demonstration of specific
antibodies. A variety of serologic tests have been applied
to brucellosis, of which SAT is the most widely used (5).
In the SAT test a single serum titer of 1/160 or greater
is considered significant (6). However, early in infection
lower titers may be present; therefore, it is important to
obtain both acute and convalescent-phase sera.
Sometimes agglutination can be masked at low dilutions
of serum (zone of antibody excess or prozone), especially
when the serum contains a high titer of antibodies.
Prozone was seen in 6% of positive sera, occurring most
often at the lowest dilution (1:20 and only rarely at a
dilution of 1:80 or greater). The prozone phenomenon is
of little practical importance as long as serum samples are
routinely diluted beyond 1:320. The other false negative
situations are being blocking antibodies—that some
patients have a factor in the serum that blocked the
agglutination reaction. On the other hand, false-positive
reactions can also be seen in the SAT test and they
occasionally result from cross-reactions with antibodies to
Salmonella spp., Yersinia spp., Vibrio cholera, Francisella
tularemia or Escherichia coli O:157. False positive and
false negative reactions can be avoided by routinely
diluting the serum beyond 1/320 (1,6,7). In the present
study the prezone phenomenon was not detected in any
of the sera tested.
If the diagnosis of brucellosis cannot be achieved by
SAT because of the low titer of antibodies and the
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Table. Results of SAT and ELISA IgG / IgM tests in patients with Brucellosis and in controls.
ELISA
SAT
Positive

IgG
Negative

Positive

IgM
Negative

Positive

IgG and IgM
Negative

Positive

Negative

Patients (n = 32)

30

2

26

6

32

0

24

8

Control (n = 20)

0

20

1

19

3

17

1

17

Sensitivity

93.7

81.3

93.8

75.0

Specificity

100.0

95.0

85.0

94.4

PPV

100.0

96.3

90.9

96.0

NPV

90.9

76.0

89.5

68.0

PPV = Positive predictive value;

NPV = Negative predictive value

presence of blocking antibodies, Brucella IgG-specific
and IgM-specific ELISA test systems have been shown to
be an acceptable alternative to SAT for the diagnosis of
subacute and chronic brucellosis. The detection of
specific immunoglobulins by a single, simple and rapid
test is a major advantage of ELISA (8). However,
occasionally false positive results may occur in ELISA
because of nonspecific binding of bovine IgM by smooth
LPS from B. abortus when the latter is used as the solidphase antigen.
Kostoula et al. reported that ELISA appears to be
more sensitive than the tube agglutination test for the
diagnosis of human brucellosis, because this method
detects specific IgG, IgM and IgA antibodies (9). Gazapo
et al. stated that ELISA IgG and IgM positivity are helpful
for epidemiological evaluations, whereas some false
positive results can be obtained in classical tube
agglutination tests due to the cross reactivity between
Brucella spp. and Salmonella spp., Vibrio cholera and
Yersinia bacteria (8). As is well known, incomplete
antibodies are commonly seen in subacute and chronic
brucellosis, and so ELISA is recommended by some
authors as a susceptible test for the diagnosis of such
cases and it was asserted that ELISA could detect
incomplete antibodies (10,11).
In the present study, in which the diagnostic values of
SAT and ELISA IgM and ELISA IgG tests were compared
in Brucella bacteremia cases, 30 of the 32 patients’ sera
gave positive results in the SAT test (93.8%). ELISA IgM
and ELISA IgG tests were positive in 32 (100%) and in

26 (81.3%) of the patients, respectively. Both ELISA IgG
and IgM positivity was 75% (in 24 of 32). These results
indicated that ELISA IgM and ELISA IgG tests had low
specificity (85%, 95%) compared to SAT (100%). Early
in infection, antibodies of the IgM class predominate,
followed shortly by a switch to IgG antibodies. In the
patients, 24 (75%) sera gave positive results with both
ELISA IgG and IgM tests. The reason why the positivity of
ELISA IgM is higher than that of ELISA IgG is that the
cases were in acute phases. In many studies performed
with ELISA, it was determined that IgG positivity and the
increasing of the antibody titers were considerably
valuable in relapsed cases and in patients with chronic
infections (12,13).
Previous studies report that the IgM antibody may be
detected after the first week following the entry of the
organism. The peak level is reached 4 weeks later (14).
The IgG antibody has a delayed appearance, although it is
found together with IgM 4 weeks after the initial
antigenic stimulus; the IgM antibody level always exceeds
the IgG antibody level in the acute stage of the disease. In
the study by Memish et al., where all the patients had
acute cases of brucellosis with bacteremia, the IgM test
was more sensitive than the IgG (5). Similarly, Gad ElRab detected only IgM antibodies in few patients with
acute disease as well (15).
Memish et al. reported that in patients with Brucella
bacteremia, the sensitivity of either ELISA IgM or IgG was
lower than that of SAT; however, combining IgM and IgG
had similar sensitivity and specificity to SAT (5).
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Güneri and Ö¤ütman, who studied 29 patients with
brucellosis, compared the ELISA and SAT tests, and found
positive results in 80% of the patients by SAT and 72%
by ELISA (16).
Sirmatel et al. found that the SAT positivity rate were
significantly higher than the ELISA IgG and IgM rates in
patients with acute brucellosis (17).
In a study conducted using ELISA in Kuwait, Brucella
IgG had a sensitivity and specificity of 98% for patients
with acute or chronic brucellosis, while Brucella IgM had
a sensitivity of 98% and a specificity of 98% for
patients with acute brucellosis. However, in patients
with chronic brucellosis the Brucella IgM was very low.
The authors of the study reported that Brucella ELISA is
a rapid, sensitive and specific assay providing a profile
of immunoglobulin classes in the diagnosis of acute and
chronic brucellosis; therefore, it is useful for mass
screening and could be considered the method of choice
for the serological diagnosis of the named disease (18).

Turk J Med Sci

Similarly, in the study by Prado et al., the sensitivities
were 65.8%, 92.6% and 85.3% for SAT, ELISA IgG
and ELISA IgM, respectively (19).
In contrast to our findings, several studies have
demonstrated that ELISA is more sensitive and rapid than
SAT and other conventional tests used in the diagnosis of
brucellosis. It is said that the detection of specific
immunoglobulins by a single, simple and rapid test is a
major advantage of ELISA (12,20,21).

Conclusion
The overall data in the present study showed that the
sensitivity of SAT and ELISA IgM tests were nearly equal,
but the sensitivity of ELISA IgG was lower than that of
the other two. On the other hand, the specificity of SAT
was higher than that of both ELISA IgG and IgM.
According to the results of our study, SAT may be
preferred to ELISA in acute brucellosis because it is cheap
and easily applicable.
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